Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP204144.RAWj_LiL9M99I9e-5uAr05pBXEB1Ym7gcl3jBkX-JrTl4130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP204144.RAWj_LiL9M99I9e-5uAr05pBXEB1Ym7gcl3jBkX-JrTl4130_provenance.
• NP653784.RAADZzYMCGmdMSVJ-BNLSM3VabmPBfoFqaEI03Nr7nri8130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP653784.RAADZzYMCGmdMSVJ-BNLSM3VabmPBfoFqaEI03Nr7nri8130_provenance.
• NP280908.RAUGyF6hyv5Gpa06TozpPMqbPMS2JuE3LdFEIxOP8ntHU130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP280908.RAUGyF6hyv5Gpa06TozpPMqbPMS2JuE3LdFEIxOP8ntHU130_provenance.
• NP494561.RAz-J8BDSCn8CQLLiQ4ObfNZAjdqOHJCDKyZvNiu3GcFw130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494561.RAz-J8BDSCn8CQLLiQ4ObfNZAjdqOHJCDKyZvNiu3GcFw130_provenance.
• NP537453.RA5wMsezRpLUjnGFouo1G5IOetF4bQPE-XKCCUnzwHpKc130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537453.RA5wMsezRpLUjnGFouo1G5IOetF4bQPE-XKCCUnzwHpKc130_provenance.
• NP625236.RAbPCeLafo50tPI5SEkdlw5hP6yaNzm1IcBKX-T4jb5Pk130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625236.RAbPCeLafo50tPI5SEkdlw5hP6yaNzm1IcBKX-T4jb5Pk130_provenance.
• NP621633.RAVVHhT6Oe7VQL2OZBpdudfPRx9cUs0TJDVdNAizHMgHw130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621633.RAVVHhT6Oe7VQL2OZBpdudfPRx9cUs0TJDVdNAizHMgHw130_provenance.
• NP622885.RAR7n9zg-My-6COZz1l6wuOUNu9Z0fTgHM1J6xP1mTXI0130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622885.RAR7n9zg-My-6COZz1l6wuOUNu9Z0fTgHM1J6xP1mTXI0130_provenance.
• NP946692.RAao1Upg9MWVS1wbkORF2_PHNQlPCxRoSSPgjpH9jWWo4130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946692.RAao1Upg9MWVS1wbkORF2_PHNQlPCxRoSSPgjpH9jWWo4130_provenance.
• NP946698.RAbQtp3M1VgyfAlU4M0dhQBgsZ_xeEU2oAEndx0RrU_QY130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946698.RAbQtp3M1VgyfAlU4M0dhQBgsZ_xeEU2oAEndx0RrU_QY130_provenance.
• NP822446.RAP3pu0r1uTj-XoB9ipZUUmS2qc1kZAN2hGC-Y3t8c5iM130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822446.RAP3pu0r1uTj-XoB9ipZUUmS2qc1kZAN2hGC-Y3t8c5iM130_provenance.
• NP697415.RAEMrfclxWxqS3StdNcBzVRa1Sz14UTM8J5WkhXhhs-2M130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697415.RAEMrfclxWxqS3StdNcBzVRa1Sz14UTM8J5WkhXhhs-2M130_provenance.
• NP621463.RADn0_3XqNjVKb2CoClmhzKd2EY5teYuAqzbtMzNAqIR0130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621463.RADn0_3XqNjVKb2CoClmhzKd2EY5teYuAqzbtMzNAqIR0130_provenance.
• NP624095.RAqqq95t5PvfLLb8JroztYHYPsQXE3a1L5CsNlu2Uryl8130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624095.RAqqq95t5PvfLLb8JroztYHYPsQXE3a1L5CsNlu2Uryl8130_provenance.
• NP624200.RAlb7zBmsUywJrUvViptVzqh4e_TJOJujbj_USH-AB1YI130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624200.RAlb7zBmsUywJrUvViptVzqh4e_TJOJujbj_USH-AB1YI130_provenance.
• NP946691.RAr3bmfsBgnHd-3D0Ks9zXUofDYWIxvK6VVqq46TYCE0Y130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946691.RAr3bmfsBgnHd-3D0Ks9zXUofDYWIxvK6VVqq46TYCE0Y130_provenance.
• NP622779.RAOtJkR4w4bws4NBjN-J7L0jmlt50EJIDWpHc6it4oMmg130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622779.RAOtJkR4w4bws4NBjN-J7L0jmlt50EJIDWpHc6it4oMmg130_provenance.
• NP625340.RAFIVXYIi_ZOe_Wdnre0nJbBiQMjEQPqf4XasAN0ERHWc130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625340.RAFIVXYIi_ZOe_Wdnre0nJbBiQMjEQPqf4XasAN0ERHWc130_provenance.
• NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946690.RAFf2ZrfDM-85Uixib2jKLhTlOJgTUnAB4A_sLE1rYwMo130_provenance.
• NP946695.RAL00mYg_b1zqDVGGUBGeKMAE8ExDq9xY3jA3G2-tHmKw130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946695.RAL00mYg_b1zqDVGGUBGeKMAE8ExDq9xY3jA3G2-tHmKw130_provenance.
• NP946689.RA6LABhafu3GzDJWj6fDLu5SbG92FZLqCNs2-KSghpnj0130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946689.RA6LABhafu3GzDJWj6fDLu5SbG92FZLqCNs2-KSghpnj0130_provenance.
• NP946696.RA5ITWgGPDQLTrnPcBBfViIC7e3RNpUuRCjIbFOruKlAc130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946696.RA5ITWgGPDQLTrnPcBBfViIC7e3RNpUuRCjIbFOruKlAc130_provenance.
• NP946697.RA2IVMhtUM8Zgdc0z6HwVHfSjM2TLq67AN6C8bsbx9xTw130_assertion description "[The phosphatidylinositol-3-kinase (PI3K) pathway is one of the most commonly activated signaling pathways in pancreatic cancer and is a target of interest for new therapeutic approaches.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946697.RA2IVMhtUM8Zgdc0z6HwVHfSjM2TLq67AN6C8bsbx9xTw130_provenance.